PPP2R2B and metastatic neoplasm: PPP2R2B expression showed marked downregulation in the relapsed metastatic tumors compared to the primary tumors (P = 0.0035; Fig. 1d), suggesting a correlation between PPP2R2B downregulation and trastuzumab resistance.